{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T08:25:45Z","timestamp":1774772745511,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.clml.2023.05.006","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T20:50:30Z","timestamp":1683665430000},"page":"e307-e313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of Inpatient Outcomes Between HIV Positive and Negative Hospitalizations for Autologous Stem Cell Transplant Treatment among Lymphoid Malignancies"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5932-5051","authenticated-orcid":false,"given":"Marco","family":"Ruiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1812-9753","authenticated-orcid":false,"given":"Muni","family":"Rubens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2448-6733","authenticated-orcid":false,"given":"Venkataraghavan","family":"Ramamoorthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5754-2359","authenticated-orcid":false,"given":"Carlo Briones","family":"Chavez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anshul","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clml.2023.05.006_bib0001","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/cncr.23281","article-title":"In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies: clinical and economic outcomes from the Nationwide Inpatient Sample","volume":"112","author":"Jones","year":"2008","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.clml.2023.05.006_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1083-8791(00)70047-4","article-title":"A review of autologous hematopoietic cell transplantation","volume":"6","author":"Blume","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.clml.2023.05.006_bib0003","doi-asserted-by":"crossref","first-page":"873","DOI":"10.5966\/sctm.2015-0015","article-title":"Autologous hematopoietic stem cell transplantation\u201410 years of data from a developing country","volume":"4","author":"Ali","year":"2015","journal-title":"Stem Cells Translat Med"},{"issue":"9","key":"10.1016\/j.clml.2023.05.006_bib0004","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.bbmt.2017.05.035","article-title":"Current use and trends in hematopoietic cell transplantation in the United States","volume":"23","author":"D\u2019Souza","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.clml.2023.05.006_bib0005","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current use of and trends in hematopoietic cell transplantation in the United States","volume":"26","author":"D'Souza","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.clml.2023.05.006_bib0006","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/bmt.2017.192","article-title":"Frailty: the missing piece of the pre-hematopoietic cell transplantation assessment?","volume":"53","author":"Hegde","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"33","key":"10.1016\/j.clml.2023.05.006_bib0007","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1200\/JCO.2013.50.5867","article-title":"Hematopoietic cell transplantation\u2013specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit","volume":"31","author":"Bayraktar","year":"2013","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.clml.2023.05.006_bib0008","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/cncr.23375","article-title":"Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation","volume":"112","author":"Sorror","year":"2008","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.clml.2023.05.006_bib0009","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbmt.2008.05.002","article-title":"Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma","volume":"14","author":"Wildes","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.clml.2023.05.006_bib0010","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.bbmt.2008.06.019","article-title":"Utility of comorbidity assessment in predicting transplantation-related toxicity following autologous hematopoietic stem cell transplantation for multiple myeloma","volume":"14","author":"Labont\u00e9","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"21","key":"10.1016\/j.clml.2023.05.006_bib0011","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/eurheartj\/eht528","article-title":"HIV infection and cardiovascular disease","volume":"35","author":"Hemkens","year":"2014","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.clml.2023.05.006_bib0012","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/cid\/cir627","article-title":"Premature age-related comorbidities among HIV-infected persons compared with the general population","volume":"53","author":"Guaraldi","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.clml.2023.05.006_bib0013","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1016\/S2352-3018(15)00077-6","article-title":"Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study","volume":"2","author":"Rasmussen","year":"2015","journal-title":"Lancet HIV"},{"issue":"1","key":"10.1016\/j.clml.2023.05.006_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170893","article-title":"Adherence to antiretroviral therapy (ART) in Yaound\u00e9-Cameroon: association with opportunistic infections, depression, ART regimen and side effects","volume":"12","author":"Fonsah","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.clml.2023.05.006_bib0015","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.bbmt.2010.03.019","article-title":"HIV status does not affect the outcome of autologous stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL)","volume":"16","author":"Krishnan","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"23","key":"10.1016\/j.clml.2023.05.006_bib0016","first-page":"6011","article-title":"Comparable survival between HIV+ and HIV\u2212 non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation","volume":"113","author":"D\u00edez-Mart\u00edn","year":"2009","journal-title":"Blood J Am Soc Hematol"},{"issue":"23","key":"10.1016\/j.clml.2023.05.006_bib0017","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1182\/blood-2008-12-195388","article-title":"Comparable survival between HIV+ and HIV-Hodgkin\u2019s Lymphoma (HL) and Non-Hodgkin\u2019s Lymphoma (NHL) patients undergoing an autologous peripheral blood stem cell transplantation (ASCT). A retrospective analysis of the EBMT lymphoma working party","volume":"113","author":"Diez-Martin","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.05.006_bib0018","first-page":"57","article-title":"AIDS-associated malignancies","volume":"35","author":"Akanmu","year":"2006","journal-title":"African J Med Medic Sci"},{"issue":"7","key":"10.1016\/j.clml.2023.05.006_bib0019","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/cncr.21334","article-title":"Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals","volume":"104","author":"Burgi","year":"2005","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.clml.2023.05.006_bib0020","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7326\/M14-2768","article-title":"Cumulative incidence of cancer among persons with HIV in North America: a cohort study","volume":"163","author":"Silverberg","year":"2015","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.clml.2023.05.006_bib0021","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","article-title":"Trends in cancer risk among people with AIDS in the United States 1980\u20132002","volume":"20","author":"Engels","year":"2006","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.clml.2023.05.006_bib0022","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/jnci\/djm010","article-title":"AIDS-related cancer and severity of immunosuppression in persons with AIDS","volume":"99","author":"Biggar","year":"2007","journal-title":"J Nat Cancer Inst"},{"issue":"9","key":"10.1016\/j.clml.2023.05.006_bib0023","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/cid\/cis613","article-title":"The rising challenge of non\u2013AIDS-defining cancers in HIV-infected patients","volume":"55","author":"Deeken","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"23","key":"10.1016\/j.clml.2023.05.006_bib0024","first-page":"5737","article-title":"Hodgkin lymphoma in the Swiss HIV cohort study","volume":"113","author":"Clifford","year":"2009","journal-title":"Blood J Am Soc Hematol"},{"issue":"23","key":"10.1016\/j.clml.2023.05.006_bib0025","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1002\/cncr.25530","article-title":"Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007","volume":"116","author":"Seaberg","year":"2010","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.clml.2023.05.006_bib0026","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1634\/theoncologist.10-6-412","article-title":"AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy","volume":"10","author":"Cheung","year":"2005","journal-title":"Oncolog"},{"issue":"7","key":"10.1016\/j.clml.2023.05.006_bib0027","first-page":"372","article-title":"Plasma cell disorders in HIV-infected patients: from benign gammopathy to multiple myeloma","volume":"14","author":"Dezube","year":"2004","journal-title":"AIDS Reader"},{"issue":"23","key":"10.1016\/j.clml.2023.05.006_bib0028","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"issue":"33","key":"10.1016\/j.clml.2023.05.006_bib0029","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1200\/JCO.2011.41.4193","article-title":"HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era","volume":"30","author":"Montoto","year":"2012","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clml.2023.05.006_bib0030","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/bjh.13221","article-title":"Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort","volume":"168","author":"Schommers","year":"2015","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.clml.2023.05.006_bib0031","first-page":"1050","article-title":"Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803\/AMC 071 trial","volume":"128","author":"Alvarnas","year":"2016","journal-title":"Blood J Am Soc Hematol"},{"issue":"10","key":"10.1016\/j.clml.2023.05.006_bib0032","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/s41409-019-0480-x","article-title":"Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party","volume":"54","author":"H\u00fcbel","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2023.05.006_bib0033","unstructured":"CDC. What Is the Impact of HIV on Racial and Ethnic Minorities in the U.S.? Atlanta, Georgia: Centers for Disease Control and Prevention. Available at: https:\/\/www.hiv.gov\/hiv-basics\/overview\/data-and-trends\/impact-on-racial-and-ethnic-minorities Accessed December 8, 2022.."},{"issue":"9","key":"10.1016\/j.clml.2023.05.006_bib0034","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/cncr.30526","article-title":"Racial disparities in treatment use for multiple myeloma","volume":"123","author":"Fiala","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2023.05.006_bib0035","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1182\/blood-2019-130859","article-title":"Racial and socioeconomic disparities in the utilization of autologous stem cell transplant for treatment of multiple myeloma in the era of novel agents","volume":"134","author":"Vardell","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.05.006_bib0036","unstructured":"DHHS. U.S. Statistics. Washington, D.C.: United States Department of Health and Human Services. Available at: https:\/\/www.hiv.gov\/hiv-basics\/overview\/data-and-trends\/statistics Accessed December 10, 2022."},{"key":"10.1016\/j.clml.2023.05.006_bib0037","unstructured":"CDC. Cancer Data and Statistics. Atlanta, Georgia: Centers for Disease Control and Prevention. Available at: https:\/\/www.cdc.gov\/cancer\/dcpc\/data\/index.htm Accessed December 12, 2022."},{"key":"10.1016\/j.clml.2023.05.006_bib0038","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ypmed.2016.04.009","article-title":"Disparities in the prevalence of comorbidities among US adults by state Medicaid expansion status","volume":"88","author":"Akinyemiju","year":"2016","journal-title":"Prevent Med"},{"key":"10.1016\/j.clml.2023.05.006_bib0039","unstructured":"AHRQ. Requirements For Publishing With HCUP Data. Available at: https:\/\/www.hcup-us.ahrq.gov\/db\/publishing.jsp. Accessed December 1, 2022."}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265023001581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265023001581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:43:24Z","timestamp":1761871404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265023001581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2152265023001581"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2023.05.006","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Inpatient Outcomes Between HIV Positive and Negative Hospitalizations for Autologous Stem Cell Transplant Treatment among Lymphoid Malignancies","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2023.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}